The patient underwent segmentectomy (S5-S4b) with cholecystectomy (16/SEP/2019) with the histopathological recognition of neuroendocrine tumor (NET) metastasis to the liver characterized as NET G2, Ki67—5%, with positive (+) chromogranin A, synaptophysin, cytokeratin, and CD56, and negative (−) TTF-1 and CDX-2. The gene discussed is SYP; the disease is neuroendocrine neoplasm.